Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RMGBU
2676
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
| $8.93M | ﹤0.01% |
+800,863
| New | +$8.53M |
|
|
CLVS
2677
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.92M | ﹤0.01% |
1,857,735
+333,219
| +22% | +$1.69M |
|
2678
Equifax
EFX
$21.2B
| $8.92M | ﹤0.01% |
46,234
-44,821
| -49% | -$7.54M |
|
2679
CALL
International Flavors & Fragrances
IFF
$21.5B
| $8.91M | ﹤0.01% |
81,900
-111,200
| -58% | -$12.5M |
|
2680
CALL
iShares Core US Aggregate Bond ETF
AGG
$138B
| $8.91M | ﹤0.01% |
75,400
+24,800
| +49% | +$2.92M |
|
2681
MillerKnoll
MLKN
$1.62B
| $8.88M | ﹤0.01% |
262,841
-96,402
| -27% | -$3.36M |
|
|
BERY
2682
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $8.88M | ﹤0.01% |
172,171
+120,661
| +234% | +$5.76M |
|
|
GRA
2683
DELISTED
W.R. Grace & Co.
GRA
| $8.88M | ﹤0.01% |
161,983
+102,281
| +171% | +$5.15M |
|
|
ATAC.U
2684
DELISTED
Altimar Acquisition Corp Units
ATAC.U
| $8.88M | ﹤0.01% |
+735,954
| New | +$7.76M |
|
2685
PUT
Coherent
COHR
$63.7B
| $8.87M | ﹤0.01% |
116,808
+28,208
| +32% | +$1.67M |
|
2686
OppFi
OPFI
$610M
| $8.87M | ﹤0.01% |
+871,425
| New | +$8.75M |
|
2687
PUT
Arrowhead Research
ARWR
$12.2B
| $8.87M | ﹤0.01% |
115,600
-51,100
| -31% | -$3.27M |
|
2688
CALL
UWM Holdings
UWMC
$2.55B
| $8.87M | ﹤0.01% |
+675,500
| New | +$7.07M |
|
2689
CALL
Clover Health Investments
CLOV
$2.44B
| $8.87M | ﹤0.01% |
+528,700
| New | +$5.89M |
|
|
NUAN
2690
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $8.86M | ﹤0.01% |
201,000
+38,400
| +24% | +$1.46M |
|
|
THS
2691
DELISTED
Treehouse Foods
THS
| $8.86M | ﹤0.01% |
208,444
-151,612
| -42% | -$6.17M |
|
2692
ProShares UltraPro Dow 30
UDOW
$924M
| $8.85M | ﹤0.01% |
345,652
+68,328
| +25% | +$1.52M |
|
|
NBIS
2693
CALL
Nebius Group N.V.
NBIS
$75.5B
| $8.85M | ﹤0.01% |
127,200
-30,900
| -20% | -$1.97M |
|
2694
PUT
TE Connectivity
TEL
$62.6B
| $8.85M | ﹤0.01% |
73,100
-4,900
| -6% | -$540K |
|
|
ELME
2695
Elme Communities
ELME
$144M
| $8.83M | ﹤0.01% |
408,411
+395,793
| +3,137% | +$8.47M |
|
2696
iShares Biotechnology ETF
IBB
$9.73B
| $8.83M | ﹤0.01% |
58,295
-4,477
| -7% | -$640K |
|
2697
Hecla Mining
HL
$12.3B
| $8.82M | ﹤0.01% |
1,361,549
-144,410
| -10% | -$769K |
|
2698
Health Catalyst
HCAT
$139M
| $8.81M | ﹤0.01% |
202,423
+19,335
| +11% | +$713K |
|
2699
CALL
Upwork
UPWK
$1.06B
| $8.81M | ﹤0.01% |
255,200
+165,900
| +186% | +$4.74M |
|
2700
PUT
Devon Energy
DVN
$50.4B
| $8.78M | ﹤0.01% |
555,600
-172,100
| -24% | -$2.13M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.